−0.105AUD
−24.51 MAUD
33.41 MAUD
141.66 M
About NEXT SCIENCE LIMITED
Sector
Industry
CEO
Harry Thomas Hall
Website
Headquarters
Sydney
Founded
2017
ISIN
AU0000041329
FIGI
BBG00NKWLWT1
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NXS is 0.315 AUD — it has decreased by 25.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEXT SCIENCE LIMITED stocks are traded under the ticker NXS.
NEXT SCIENCE LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
NXS stock is 35.48% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is NEXT SCIENCE LIMITED there?
NXS earnings for the last quarter are −0.06 AUD per share, whereas the estimation was −0.03 AUD resulting in a −122.78% surprise. The estimated earnings for the next quarter are −0.04 AUD per share. See more details about NEXT SCIENCE LIMITED earnings.
NEXT SCIENCE LIMITED revenue for the last quarter amounts to 15.18 M AUD despite the estimated figure of 15.02 M AUD. In the next quarter revenue is expected to reach 17.77 M AUD.
Yes, you can track NEXT SCIENCE LIMITED financials in yearly and quarterly reports right on TradingView.
NXS stock has fallen by 21.25% compared to the previous week, the month change is a 17.11% fall, over the last year NEXT SCIENCE LIMITED has showed a 55.94% decrease.
NXS net income for the last quarter is −11.74 M AUD, while the quarter before that showed −12.75 M AUD of net income which accounts for 7.95% change. Track more NEXT SCIENCE LIMITED financial stats to get the full picture.
Today NEXT SCIENCE LIMITED has the market capitalization of 122.51 M, it has increased by 11.84% over the last week.
No, NXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXT SCIENCE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXT SCIENCE LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXT SCIENCE LIMITED stock shows the sell signal. See more of NEXT SCIENCE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NEXT SCIENCE LIMITED future price: according to them, NXS price has a max estimate of 0.40 AUD and a min estimate of 0.34 AUD. Read a more detailed NEXT SCIENCE LIMITED forecast: see what analysts think of NEXT SCIENCE LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXT SCIENCE LIMITED EBITDA is −22.45 M AUD, and current EBITDA margin is −67.24%. See more stats in NEXT SCIENCE LIMITED financial statements.